Protocols
Prodermic TXA. sr is a premium melasma maintenance serum that targets pigmentation through a fundamentally different pathway than acid-based or standard brightening approaches.
Prodermic TXA.sr is a premium melasma maintenance serum that targets pigmentation through a fundamentally different pathway than acid-based or standard brightening approaches.Tranexamic Acid 5% blocks the hormonal and UV-triggered signals that cause pigmentation in the first place. Azelaic Acid 3% provides anti-inflammatory and pigment-reducing dual action. Niacinamide 10% stops pigment transfer from pigment-producing cells to surrounding skin cells. Hyaluronic Acid 1% maintains barrier hydration. Total active load: 19%.Addresses hormonal and vascular components of melasma that conventional agents cannot reach. ~75 sessions per 30ml bottle.
TANH-4 Complex — Tranexamic Acid 5% with azelaic acid anti-inflammatory action, niacinamide pigment-transfer blocking, and hyaluronic acid barrier support.Tranexamic Acid 5% blocks the UV-triggered and hormonal signaling cascade that tells pigment cells to produce melanin, interrupting the cause of pigmentation at its source. Azelaic Acid 3% provides anti-inflammatory action while selectively targeting overactive pigment cells. Niacinamide 10% stops pigment transfer to prevent visible discoloration even when melanin is produced. Hyaluronic Acid 1% ensures barrier health during continuous depigmentation.A completely different approach to melasma — addresses the root triggers, not just the symptoms.
Recommended sequence for prodermic TXA.sr. Frequency: Daily (AM/PM).
Hormonal melasma, recurrent melasma despite peel treatment, patients on hormonal medication, premium upsell for severe melasma cases
If desired results are not achieved, it does not indicate the peel is ineffective—it may simply mean that the skin has a higher tolerance to the current formulation. In such cases, consider transitioning to a stronger peel, applying multiple coats, or increasing the application time in subsequent sessions.
